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INTRODUCTION
In 1743, Hunter stated, "From Hippocrates to the present
age it is universally allowed that ulcerated cartilage is a
troublesome thing and when once destroyed it is not repaired."^
From his century, to ours, his words ring true, as researchers
investigate the complex and seemingly mysterious mechanisms of
cartilage pathophysiology.
Recent reports of cartilage destruction associated with the
oral administration of fluoroquinolone analoges have baffled
investigators. 2. 3 These broad-spectrum antibacterial agents,
composed of a 4-quinolone nucleus and a carboxylate substituent
at position 3, have been used successfully against many systemic
infections. However, high-level oral dosages with prolonged
therapy induced articular cartilage changes in immature animals.
This effect has been reported in immature rabbits,^ dogs,^ and
monkeys. 5 Articular cartilage had previously been considered
resistant to adverse effects from systemically administered
drugs."
Typically, the lesions appeared grossly as blister-like
elevated vesicles, on the articular surface of major joints. The
vesicles coalesced, increasing their diameter and fragility, which
led to tearing and focal articular cartilage effacement. Despite
the multiple locations, and activity-enhanced lesion-severity, the
dogs remained weight-bearing and active. Microscopically, the
findings included foci of chondromalacia, chondrocyte clusters.
fibrillation, and clefting. 2.
3
This study evaluates lesions produced in puppies after high
level and prolonged duration oral fluoroquinolone treatment. The
objective of this study is to illustrate the cartilagenous lesion
progression initiated by oral fluoroquinolone administration.
I. REVIEW OF LITERATURE
LITERATURE REVIEW
Articular cartilage is a highly specialized form of connective
tissue well-suited for its dual role as a shock absorber and
weight bearing surface in a moveable joint. The composition of
articular cartilage suggested to early investigators that it was
an inert hypometabolic connective tissue structure. The opposite
has since proved true.
Articular cartilage is the workhorse of diarthroidal joints,
where it provides almost frictionless movement of the articulating
surfaces as well as necessary resiliency. Cartilage is firmly
attached to the underlying subchondral cortical bone, and
measures less than 5 mm in thickness in mammalian joints,
though species, joint, and site variations occur.7»8 Surprisingly,
articular surface is not smooth. ^ Electron microscopy illustrated
gentle undulations and irregular depressions. Constituents of
cartilage include cells, collagen, and a gel-like ground
substance whose combined properties lend resiliency and
structure.
Cellular Component
The cellular component of cartilage may be divided into 4.
Zone 1, referred to as a tangential or gliding zone, contains
elongated cells with their long axes parallel to the surface
residing in a less developed proteoglycan matrix.
Merging into this region is zone 2, or transitional zone,
where randomly distributed chondrocytes are round or ovoid. Zone
2 is the most raetabolically active layer of articular cartilage.
Electron microscopy of chondrocytes demonstrated extensive
networks of rough endoplasmic reticulum, dilated cisternae,
vacuoles and Golgi apparatus, suggesting protein synthesis and
matrix production. 1° Radioactive isotope studies illustrated
chondrocytic synthesis of macromolecular proteoglycan and
collagen component portions, assembled intracellularly and
rapidly extruded into the surrounding matrix. 11-17 x^e secretions
envelope chondrocytes which become isolated in their lacunae.
Chondroblasts maturing into chondrocytes undergo cellular
hypertrophy and enlargement of the flattened lacunae to an ovoid
angular shape.
Zone 2 gives way to the columnar zone 3, or radial zone.
The cells are lined up in short, irregular columns, which become
longer and the cells larger in the deeper part of the cartilage.
Clusters of chondrocytes as isogenous groups or cell nests occur.
The cell nests represent daughter cells of a single chondrocyte
that underwent mitosis (interstitial growth).
The calcified zone of zone 4 contains matrix and cells
heavily encrusted with hydroxyapatite. Zone L, is separated from
the radial zone by an irregular bluish line, the "tidemark" and
on its deep surface the zone merges with the end-plate of the
underlying bone. 18, 19
Matrical Component
Aside from the metabolically active cellular component of
articular cartilage, there is the chondrocyte-generated matrix.
Its constituents are macromolecular organic solids consisting
equally of randomly interwoven fibrous type II collagen and
gel-like proteoglycan ground substance. 20, 21
To picture the gel-like matrix, imagine a bottle brush
representation of cartilage proteoglycans, with a protein core and
a large number of attached glycosaminoglycan chains of
chondroitin sulfate. 22 Chondroitin-6-sulfate is the principal
glycosaminoglycan, accounting for A5 to 75% of the sugar
component of hyaline cartilage and roughly 15% of its dry
weight. 23 in immature articular cartilage, chondroitin-4-sulfate
is more prevalent, and decreases in concentration with age, to
the adult level of less than 5% of the total glycosaminoglycan
concentration .23 Concomitt a
n
tly
, a third type of
glycosaminoglycan, keratin sulfate, increases with animal age.
Mourao et al. found that chondroitin-4-sulfate seems to be related
to ossification, whereas chondroitin-6-sulfate assumes a major
role in the maintenance of articular surfaces. 24
Assessing metabolic turnover of proteoglycans is difficult as
metabolic "pools" of proteoglycans exist in the matrix. 25 Research
suggests considerable variation occurs in turnover rates of
glycosaminoglycans corresponding with the depth in articular
cartilage in between different joints. Age also appears to
generally decrease the turnover of proteoglycans. 26 The collagen
component is also metabolically active, but turnover occurs at a
much slower rate. 27
Cartilage collagen, categorized as type II, differs from type
I collagen of skin or bone. Type II collagen consists of 3
ill chains in a helical arrangement, however type I
contains 2
^ ^^ ^ chains. ^8-31 Type II collagen chains differ
from those of type I principally in the increased quantity of hy-
droxylysine and excessive glycosylation.29,30
Collagen fibers assume an arcade-like arrangement in
articular cartilage, spanning 3 architectural zones. The deepest
zone, found adjacent to subchondral bone, help to secure
cartilage to bone. This radial zone incorporates collagen fibers
oriented perpendicular to the subchondral bone.
An intermediate zone assumes a haphazard formation, similar
to randomly arranged zone 2 chondrocytes. The most superficial
layer lies parallel to the articular surface an comprises the
tangential zone. This arcade formation aids cartilage
compressibility and elasticity. 32, 33
Articular cartilage is a hyperhydrated tissue with water
content estimates ranging as high as 80% in the immature
animal. 34, 35 Water content is higher near the surface, with zone
A cartilage containing the least water. 36 xhis unique hydrophilic
property is established by the extensive negative field generated
from the polyionic glycosaminoglycan configuration. The negative
charges repel one another, causing the macromolecule to rest
stiffly extended in its electrostatic "domain". Linkage of glyco-
saminoglycans occurs via hyaluronate and two glycoproteins.
8forming a stiffly extended hydrophilic macromolecule bonded to
collagen molecules. 37-40 such architecture increases the density
of the matrix and the aggregates provide three significant matri-
cal functions; stability, volume definition, and compressive
properties
.
Stability is derived from linkage of proteoglycans to
hyaluronic acid and collagen fibers in a unique spatial
arrangement, allowing maximum surface area for entrapping
interstitial fluid. Efficient fluid absorption ability of
proteoglycans enables remarkable cartilage volume definition, and
is also responsible for cartilage hydrodynamics. Proteoglycan
aggregates are resistant to compressive forces. Applied pressure
will decrease their volume proportionally to the amount of force
and upon removal of pressure, the macromolecules return to their
original volume. Charge densities also play a role in
hydrodynamics. As the volume of proteoglycan aggregates
decrease, the charge density and mobility restraints of these
polyions increase.
The essential hydrodynamic properties are lost if the
synthesis or proper formation of the proteoglycan aggregates is
compromised. Such a change would alter the effective fluid
entrapment abilities of the cartilagenous matrix and increase
cartilage compressibility. Tissue damage increases with the loss
of hydrodynamic cartilage resistance.
Articular Cartilage Nutrition
'W^
Articular cartilage is isolated in the sense that it lacks
direct vascularity, lymphatics and nerves. Nutrients must pass
through a double diffusion barrier in order to reach the cells.
In the mature adults, all nutrients must first diffuse out of the
synovial vascular plexus, traverse the synovial membrane to
enter synovial fluid, and pass through the dense hyaline matrix
of cartilage to reach the chondrocytes. ^1
In immature animals, nutrient diffusion from underlying bone
vasculature to the basilar layer of cartilage can occur, in
addition to nutrition from synovial fluid. A2 j^ie source of
nutrients is the plexuses of vessels in the subchondral cancellous
tissue and vessels of the joint capsule. ^3
Exercise plays an integral role in pumping nutrient-rich
synovial fluid through cartilagenous matrix to the chondrocytes.
The rate-limiting feature of nutrient diffusion into articular
cartilage is the cartilagenous matrix pore size, theoretically
established as 6.9 nm (68A) .41.42.44.45 Even low molecular
weight proteins diffuse slowly across this barrier. The
facilitation for nutrient diffusion is exercise, which plays an
integral role in pumping nutrient-rich synovial fluid through
cartilagenous matrix to chondrocytes.
Because of its compressability, cartilage under pressure, can
behave like a sponge. 46 During pressure fluid is expressed, and
when pressure is released, fluid is reabsorbed. Numerous
repetitions of such impact cycles favor local penetration by
molecules otherwise considered too large to make their way
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unaided into the dense structure of normal cartilage. Research
has shown that without exercise the cells atrophy, lacunae
merge to form cysts, surface integrity is lost and disintegration
of the articular plate occurs. ^3
Synovial fluid functions to lubricate articular cartilage
surfaces, provide nutrition and protect joint surfaces. This super
blood dialysate incorporates glycosarainoglycans
,
predominatly
hyaluronic acid, to provide viscosity. Other components of
synovial fluid include degraded products of cartilagenous matrix
and synovial lining cells, lysosomal enzymes, and articular
cartilage constituents that leached or "wept" into synovial fluid.
Growth and Remodeling of Articular Cartilage
Most critical when discussing healing abilities is the
potential of chondrocytes to reproduce. Cell replication is evident
in immature cartilage, but even in young animals, mitotic
activity is not uniform. Two distinct zones of replication occur,
both in the middle regions of cartilage. ^^7, 48
-p^g ^^^.g^ ^^g
subjacent to the articular surface for which it account for the
region's cellular growth. Located deeper in this area is the
second zone of cells whose narrow band resembles the
proliferative zone of a bone's microepiphyseal plate. -48
The pattern changes as the animal ages and approaches
maturity. The mitotic index decreases, and only one zone
remains, located above the zone of vascular invasion in the
deeper layers of cartilage. 49 At skeletal maturity, which
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generally coincides with epiphyseal closure, mitotic activity
appears to cease. The unanswered question was whether this
apparent inability to replicate was reversible, allowing DNA
synthesis and cell replication under certain circumstances.
Studies indicated termination of DNA synthesis was due to
replicatory apparatus suppression rather than permanent
structural damage or change to the synthesis mechanism. 6 Thus
chondrocytes can, under appropriate conditions, display
replicative abilities.
Previously regarded "inert" cartilage initiates a constant
rate of synthesis and degradation of its matrical components.
Articular chondrocytes are responsible for proteoglycan synthesis,
a small portion of which rapidly turns over. 50-53 Collagen is
also partly synthesized by local chondrocytes, but is more stable
than the proteoglycan component. 27, 56 Cartilage incorporates an
active internal remodeling system through autodegradative
lysosomal enzymes that act upon proteoglycan. 54, 55 xhe specific
enzymes involved remain unidentified although cathepsin D and a
neutral proteoglycanase are likely. 25, 57, 58 ^ collagenase which
degrades cartilage collagen has been found in tissues from
osteoarthritic human joints, but not in normal articular
cartilage.59
Response of Articular Cartilage to Injury
Since Hunter's observation in 1743, researchers have found
that injuries confined exclusively to cartilage of adult animals
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fail to repair effectively. A major limitation is lack of an
inflammatory element in the avascular cartilage meshwork. Repair
is independent of extent or depth of the lesion, and is
characterized by minimal attempts on the part of the cartilage to
add cellular and matrix elements. 60~62.
Immediately after superficial injury, a burst of mitotic
activity is detected adjacent to the damaged sites, which
correlated with increased synthesis of matrix components. 62
Unfortunately, the reparative effort is short-lived and falls back
to normal levels one week post-injury. ^2
Partial thickness defects in articular cartilage of rabbits
were produced by Fuller and Ghadially in their cartilage
research. 63 They found no significant repair reaction, even in
young animals. Through electron microscopy, they recorded cell
death at the wound margins and increased cellular activity from
surviving chondrocytes. Nuclear hypertrophy, increased quantities
of rough endoplasmic reticulum, and occasional increased numbers
of Golgi complexes, were noted after injury, but by 6 months,
the defect remained and healing processes had ceased. 63 Similar
long-term research reported the lesions remain stable and
osteoarthritic changes occurred only occasionally. 64-66
In contrast, deeper lesions involving subchondral
vasculature, initiate an inflammatory response. Initially, fibrous
tissue fills the defect, which becomes progressively chondrified to
form a fibrocartilagenous mass. However, a 12-month study by
Mitchell and Shepard, found fibrocartilagenous material became
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more fibrous with time. 52 The surface layers became fibrillated,
although the deep, cartilage-filled defect remained unchanged,
and function seemed unimpaired.
Degenerative Cartilage Changes
Degenerative cartilage lesions attributed to osteroarthrotic
conditions differ from superficial lacerative injuries. Primary
degenerative joint disease is attributed to trauma or constant
wear on a joint surface. One theory is that trauma to articular
surfaces allows an increased amount of synovial fluid to
penetrate the articular matrix. The hyaluronidase faction begins
to break down the proteoglycan matrix. 67 stress on the now
weakened cartilage induces cracks and fissures, which in turn
allows more synovial fluid to enter. 68
Another popular theory implies indirect degradation occurs
by factors, which stimulate chondrocyte production of
matrix-degrading enzymes. Fell and Jubb first demonstrated that
live synovial tissue induced cartilage matrix depletion when
co-cultured in the same dish, though not in contact with live
cartilage explants, whereas no depletion was found with dead
cartilage. 69 Dingle and Dingle have shown that matrix degrading
activity occurred only in the pericellular area in cartilage
explants, close to chondrocyte membranes. 70 Current in vitro
studies of articular cartilage explants, cultured with blood
mononuclear cell supernates, elicited degradation of matrix
proteoglycan and collagen. 71
uGrossly, the degenerated articular surfaces are yellowish and
less elastic than normal, with roughened foci. Chondromalacia is
an early sign of weakened cartilage matrix due to proteoglycan
loss. 72-76 The softened cartilage is unable to support the
collagen framework, a situation aided by weight-bearing stress.
Fibrillation, the term describing exposure of the collagen arcade
through the loss of ground substance results, as well as
irregular surface depressions. 75, 76
Typically, the microscopic appearance of chondromalacia is a
notable loss in metachromasia. The articular cartilate is pale,
hypocellular, and pink with H & E stain. Clustering of
chondrocytes, or "chondrones" are found, and believed to
represent an abortive repair effort. 76 as fibrillation continues,
the more severe fissuring, or vertical cleft formation is noted,
extending into deeper zones. Erosion may continue to subchondral
bone, where mechanical forces and synovial fluid act to polish
its surface, by a process termed eburnation.32,77
One biochemical change early in degeneration is an increase
in cartilage water content. One explanation is increased bonding
of water to collagen molecules occurs, 78 qj. ^ ^g ^^le result of
damaged collagen network failing to oppose swelling pressure of
proteoglycans. 79 The unfolding proteoglycans were able to bind
9% more water. 78
Research also detected a significant increase in synthetic
activity in the early stages of osteoarthritis, prior to gross
disruption of the cartilage surfaces. 80 in effect, the cells
uattempt to replenish their matrix in the face of increased
degradation.
Responding to this increased demand, the matrix components
undergo change. A significant increase in chondroitin-4-sulfate
occurs, and a decrease in keratin sulfate. 23 This pattern is
attributed to chondrocytes responding by producing younger
cartilage, or reverting to a chondroblastic phase.
Collagen synthesis, too, is varied. Degenerative cartilage
manufactures Type 1 collagen, found in bone or skin, rather
than the normal Type 11 collagen. ^1
of transcription, DNA repair, recombination, and transposition.
Fluoroquinolone Family of Antibacterial Agents
In recent years, newly developed 4-quinolone-3-carboxylates
have generated attention for their scope and effectiveness against
Gram-negative bacilli and cocci in vitro
, and their capacity to
control experimentally-induced systmeic bacterial infections when
given orally. 82 x^e family of fluoroquinolone antibiotics include
new additions of norfloxacin, ofloxacin, ciprofloxacin,
amifloxacin, enoxacin and pefloxacin, as well as nalidixic and
oxolinic acids, among others.
The fluoroquinolone mechanism of action is directed against
bacterial DNA gyrase, an essential bacterial enzyme that
maintains DNA superhelical twists. 23, 84, 85 dnA gyrase introduces
negative superhelical twists into double-stranded DNA, which
allows unwinding of the double strands. Double-stranded breaks
are made in DNA by DNA gyrase, another DNA duplex passes
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through the break, and cut strands are released. By these
methods, DNA gyrase is essential for DNA replication, and certain
aspects of transcription, DNA repair, recombination, and
transposition.
Each chromosomal domain is independently supercoiled by DNA
gyrase, and gyrase action upon each domain occurs at a single
specific site. Quinolones can affect gyrase action by preventing
sealing of the single-strand gaps, which inhibits DNA
supercoiling
,
thereby increasing the spatial requirements within
the bacterial cell. 86 Researchers have found that bacteria treated
with quinolone elongate abnormally. 86
The exact mechanism of action by fluoroquinolones has yet to
be fully clarified. Recent results suggest that norfloxacin and
other quinolones bind to purified DNA rather than to purified DNA
gyrase. 87 The exact bactericidal mechanism is not known, 88, 89
but may involve cleavage of bacterial chromosomal DNA by DNA
gyrase. Quinolones kill bacteria rapidly, with as much as a
thousand fold decrease in viability in 1 to 2 hours of drug
exposure at 1 to 4 times the Minimum Inhibitory Concentration
(MIC) .88,90-96
Toxicity trials have shown quinolone antibacterials are
generally well tolerated, with the most notable toxic effect
observed being erosion of articular cartilage in immature
animals. This effect has been reported for naladixic, oxolinic,
cinoxacin, pipemidic acid and piromidic acid. It was shown to
occur in rabbits, 4 dogs, 3 and monkeys, 5 and only in immature
16
animals. 53 Reported clinical side effects include dizziness, visual
disturbances, hemolytic anemia, photosensitivity, and intracranial
hypertension. 97
Previous In Vivo Studies
Several reports of pharmaceutical trials testing oxolinic and
pipemidic acid in juvenile dogs indicated fluoroquinolone-mediated
articular cartilage erosion. Gough et al. tested 4 groups of
3-month-old beagles given oxolinic acid at 500 to 100 mg/kg, or
pipemidic acid at 500 mg/kg, orally dosed twice daily. 3 a
similar study by Ingham et al. tested 4 12-raonth-old beagles,
orally dosed with 200-1,000 mg/kg per day of pipemidic acid for
period of 1-15 days. 2 The dogs were necropsied from 1-87 days
after completion of the dosage regimen. Other groups of L, beagles
each, were treated daily for 6 months with 0, 50, 100, or 200,
increasing to 350 mg/kg pipemidic acid. The dogs were necropsied
immediately following treatment.
Gough and coworkers prepared a grading criteria of gross
and microscopic lesions for evaluation^
Grade Gross Microscopic
No lesions seen No lesions detected
1 small, 1-3 mm diameter Discrete matrix loss,
vesicle, on articular surface cartilage fibrillation,
and chondrocyte
clusters.
1-2 vesicles or bulla, more Fissuring of matrix,
than 3 mm diameter and microcavitations
not seen grossly.
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3 More than 2 vesicles or Zone 2 cavitations,
^^11^^ and cartilage surface
elevations correlating
with gross.
4 Surface erosion & cartilage Large cavities, matrix
effacement loss, irregular frag-
mentation.
Clinically, Gough et al. observed increased motor activity in
the 500 mg/kg oxolinic acid treated group, characterized by
intense pacing from day 1 to 11. The dogs showed reluctancy to
rise, hindquarter stiffness, and stilted gait on day 12, which
disappeared once pacing began. Dogs dosed with 100 mg/kg
oxolinic acid had mildly accentuated pacing, with no sign of
lameness. Pipemidic acid inhibited spontaneous motor activity and
the dogs were unable to stand, and moved with obvious pain.
At necropsy, the carpal, humeroradial, tarsal, scapu-
lohumeral, coxofermoral and femorotibial joints were examined.
All dogs had varying degrees of articular cartilage vesiculation,
surface detachment, and complete erosion. The joints from
pipemidic acid-treated dogs contained large amounts of
blood-tinged synovial fluid.
Histopathology revealed early focal loss of cartilagenous
matrix, which evolved into cavitations. Cartilage fibrillation and
chondrocyte clustering were pronounced within the intermediate
zone. Several pipemidic acid-treated dogs developed synovial
membrane changes.
Pipedimic acid-treated dogs incurred the highest gross and
microscopic incidences, L, times higher when compared with the
oxolinic acid-treated dogs at the same dose. Lesion severity was
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dose-related between the two oxolinic acid-treated groups.
Results from Ingham's experiment concluded that clinically,
the age was of greater importance than the dosage of pipemidic
acid, as generally, the younger the dog, the earlier the onset of
arthropathy2. He found similar severe changes, gait ataxia,
stiffness, and inability to rise. However, in several cases, even
with continued medication, clinical recovery began 7-10 days
after onset of signs, and was complete within 2-3 weeks.
Lesions at necropsy were most frequently located on the
humeral head, glenoid cavity of the scapula, the head and
trochlea of the femur, and the trochlear surface of the patella.
The joints from clinically lame dogs contained large amounts of
clear synovial fluid. There was no microscopic evidence of lesion
resolution in 3 dogs necropsied 22, 26, and 87 days after
medication withdrawal, although they were no longer lame prior
to necropsy.
In a 6-month study, half of the dogs in the two highest does
rates became lame, having clinical signs after 3-U days of
treatment. All afflicted dogs had clinically recovered by the end
of the first month. Necropsy revealed blistering of the articular
surfaces in 15 out of 16 dogs. Microscopic findings in both cases
were similar to those found by Gough et al. ; however, there were
no changes in the synovial membrane of either group. Another
pipemidic acid study with beagles 2 years or older did not
produce gross or microscopic lesions.
2
Cinoxocin, another fluoroquinolone, was tested in 2-3
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month-old beagles given 250 mg/kg/day . 93 Clinical signs of
arthropathy were seen after 2-7 doses. Gross and microscopic
lesions characterized the previously described "blistering" and
cartilagenous matrix loss. Lesions were not observed grossly or
histologically in dogs 8 months old or older.
Patella
The patella is pivotal for effective stifle mechanics. Two
forces act on the patella during joint movement, a patellofemoral
compresssion force and a quadriceps muscle tension force. Studies
of human patellar bio-mechanics find that patello-femoral
compression rises sharply after 30 knee flexion. 99 xhis is
approximates the body weight. At 60 flexion, it is 4 times the
body weight.
In daily activities, this force is estimated to be 1.5 times
the body weight for walking, 3.3 times the body weight climbing
stairs, and nearly 8 times the body weight on squatting.
Quadriceps tension forces also rise after 15 knee flexion. Force
estimates by Kettelkamp are 1 times body weight for walking, 3.4
times body weight for climbing stairs, and 5 times body weight
for squatting. 99
Human medicine has documented the syndrome chondromalacia
patellae, which refers to softening of the articular cartilage of
the patella, and commonly begins in adolescents and young
adults. Classic arthritic signs of joint effusion and limited range
of movement are lacking, and the syndrome does not necessarily
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lead to patello-femoral osteoarthritis in later years.
Macroscopically, fibrillation, fissuring, and erosion of the
articular cartilage occur, and may be categorized into L,
grades. 100
I: Localized softening, swelling or fibrillation of the
articular cartilage.
II: Fragmentation and fissuring in an area 1.3 cm. or less
in diameter.
Ill: Fragmentation and fissuring in an area greater than 1.3
cm. in diameter.
IV: Erosion of articular cartilage down to subchondral bone.
Research of chondromalacia patellae, conducted by
Goodfellow et al.
,
divided the pathology of patellar articular
cartilage into age-dependent surface degeneration and basal
degeneration. 101 Age-dependent surface degeneration is commonly
encountered in its advanced form in middle-aged joints. The
articular surface is affected by fibrillation and erosion, which
progressively deepens to the subchondral bone plate. Contact
studies of articular surfaces have illustrated areas most
frequently afflicted. Surprisingly, habitually non-contract areas
undergo degeneration even in youth, and high contact areas are
les commonly affected. This is believed to be due to lack of
pressure allowing nutrients into the dense cartilage meshwork.102
Once degeneration begins, tension forces transmitted across the
articular surface are disrupted and adjacent areas breakdown. 103
Basilar degeneration, noted in young, athletic adults,
initially involved the deep cartilage zones, and only later
21
affected the articular surface. In the early stages, the surface
is smooth, though the cartilage has a spongy consistency and
"pitting edema". Fasiculation of the zone 4 region is believed to
occur, which eventually leads to surface fibrillation.
Histologically, the basilar collagen fibers were thick, and
embedded in a pale-staining ground substance. Chondrocyte
proliferation occurred within the frond-like projections in
advanced lesions. "Blistering" was also noted, though the bullae
contained a plug of unorganized fibrous tissue.
Basilar degenerative lesions developed in a different area
than normally observed for the age-dependent, surface
degenerative patellar lesions. The lesions occurred in an area of
heavy compression loading, and also subjected to shearing
forces, as the patella glides off the patellar facets and onto the
femoral condyles and back again.
Cartilage Staining Characteristics
Due to the presence of sulfate groups on proteoglycans, the
acidic ground substance matrix stains basophilic, though rarely
does cartilage stain uniformly. Staining properties are conferred
by the acidophilic nature of collagen and the basophilic
carboxylate and sulfate groups of proteoglycans. Stain intensity
and variation may be associated with age or metabolic activity
of cartilage. Young cartilage may be acidophilic, however
perilacunar matrix of old cartilage may stain strongly
basophilic. Acidophilia of younger cartilage stems from collagen
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dominating the small number of basophilic sulfate groups present.
Generally, the basophilic components predominate in routine
hematoxylin and eosin (H & E) staining.
Metachromatic stains, such as toluidine blue or Alcian blue,
are useful for demonstrating glycosaminoglycans. Other
nonspecific glycosaminoglycans of cartilagenous matrix are
periodic acid schiff (PAS) negative, however, the cartilagenous
matrix stains positively with PAS. The constituents responsible
for this staining reaction remain unidentified, though they are
probably collagen and other structural glycoproteins. 10-4
Research by Scott and Dorling undertaken to differentiate
between carboxyl and sulfated groups in glycosaminoglycans,
resulted in the technique of altering MgCl2 molarities while using
Alcian blue. 105 The technique is based on the assumption that
electrolytes (MgCl2)
^tien incorporated into the Alcian blue
staining solution, will compete with Alcian blue molecules for the
reactive constituents of the acid mucosubstances. Below .06 mol/1
S 2. both carboxylated and sulfated mucosubstances will stain;
above
.3 mol/1, only sulfated mucosubstances will stain with
Alcian blue. The anticipated results are as follows: carboxyl and
sulfated mucosubstances-positive with .06 M MgCl2., weakly and
strongly sulfated mucosubstances-positive with .3M MgCl
strongly sulfated mucosubstances-positive with .5M MgCU., highly
sulfated connective tissue mucins-positive with .7M MgCU.^ and
keratin sulfate only-positive with .9M MgCl2. Criticism of this
technique stems from false negatived resulting from poor
23
penetration by Alcian blue, and poor tissue fixation will result
in inadequate substrate with which Alcian blue can react. 106
24
Glossary
Cartilage Fibrillation - Exposure of collagen framework composing
hyaline cartilage, due to degradation of proteoglycan matrix.
Chondromalacia - Softening of cartilage as determined by loss of
sulfated proteoglycans in cartilagenous matrix. Loss of
staining on H & E.
Chondrones or chondrocyte clusters - Cellular nests that represent
chondrocyte mitosis in abortive or ineffective attempts at
repair.
Clefting - Horizontal clefts found in zone 2, surrounded by
cartilage undergoing chondromalacia.
Fissuring - Vertical clefts in articular cartilage.
Flaking
- Cracks or fissures in the surface layer of the
articular cartilage.
Matrix Rarefaction - Loss of matrix density as indicated by pale
stain uptake.
Mesochondrium
- The matrix in which are embedded the cellular
elements of hyaline cartilage.
Territorial Matrix - Refers to the lacunar margins of individual
or groups of chondrocytes. Strongly basophilic on H & E.
Interterritorial Matrix - Lighter staining region of matrix not
directly adjacent to chondrocytes.
Superficial or Surface Layer (Zone 1) - Small, flattened
chondrocytes, their long axes parallel to articular surface.
Intermediate or Transitional Layer (Zone 2) - Round cells in
various stages of maturation.
Deep Zone (Zone 3) - Mature and hypertrophic cells.
Mineralization Zone (Zone 4) - Point of union of articular
cartilage with underlying compact epiphyseal bone.
Tidemark
- Junction between noncalcified and calcified portions of
cartilage.
Bulla
-
A large vesicle, usually 2 mm or greater in diameter.
Vesicle - A blister less than 2 mm in diameter.
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II. PATHOLOGICAL STUDY OF FLUOROQUINOLONE-MEDIATED
CHONDROARTHROPATHY IN JUVENILE DOGS
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INTRODUCTION
Recent development of the promising fluoroquinolone antibiotic
family has initiated considerable toxicity-level investigation.
Prolonged administration of high oral dosages resulted in
articular cartilage changes in immature animals. This effect, by
an unknown mechanism, has been reported in rabbits, 1 dogs,
2
and monkeys, 3 though only in immature animals. 2. 3 Researchers
have suggested various pathogenetic mechanisms for the articular
changes, but the histologic initiator remains undetermined.
This report documents the gross and microscopic
development of articular cartilage lesions associated with
prolonged, high level oral fluoroquinolone administration in
immature dogs. Illustration of progressive articular changes
initiated by matrix depletion, may help clarify the degenerative
mechanism involved.
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MATERIALS AND METHODS
Thirty dogs were given a fluoroquinolone antibiotic at the
proposed use level and elevated doses, for 3 times the proposed
treatment duration. In the first trial, 15 Labrador puppies, 19-28
weeks old, were divided into L, groups, 3 test groupings
containing L, each and 1 control of 3 pups. Fluoroquinolone was
administered orally as follows:
^"^o^P Daily dosage level, 30 consecutive days
I Nontreated controls
I^ Proposed use level
I^^ 3 X proposed use level
^V 5 X proposed use level
Following the thirtieth treatment, half of the pups were
euthanized using a sodium pentobarbitol solution (Sleep-Away)
and necropsied, with the remainder examined the following week.
In the second trial 15 Labrador pups, 12-15 weeks old, were
divided into 5 groups of 3, 4 test and 1 control. The method of
selection was random, by weight.
£E2HE Daily dosage level, 30 consecutive days
I Nontreated controls
^^
.5 X proposed use level
^^^ 1.5 X proposed use level
^^ 2.5 X proposed use level
V 3 X proposed use level, for 15 days
After the thirtieth day of treatment, 2 puppies from groups I and
V, and 1 from each of the other groups were euthanized with
sodium pentobarbitol and necropsied. The remaining pups were
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necropsied 9 days post-treatment.
For histopathological examination, the coxofemoral, carpal,
and stifle joints were removed and fixed in 10% buffered, neutral
formalin (BNF). After 2 weeks, the joints were washed, and
placed in formic acid-sodium citrate solution for 10 days
*4
The solution was changed several times during the decalcification
process. Following routine processing and embedding, the tissues
were cut at 5 microns and stained with hematoxylin and eosin,^
(H & F), and 2 concentrations of Alcian blue, at .5M MgCU and
.9M MgCl25 Another mucopolysaccharide sensitive stain. Azure A,^
was also tried on several sections. The tissues were evaluated by
light microscopy
.
Sequential development of gross and microscopic lesions of
the acetabulum, femoral head, patella, distal femur, and
proximal tibia, were examined by the following criteria:
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RESULTS
I. Clinical Observations
In trial 1, 3 of the U dogs treated at 5 times the proposed
dosage level developed hindquarter weakness within 7 days of
treatment. All 3 dogs in trial 2, receiving 3 times the proposed
dose level, had hindquarter weakness and stiffness by day 11 of
treatment. Signs of this weakness had clinically resolved 9 by
days post-treatment. In both cases, the hindquarter weakness did
not appear to be painful.
II. Gross Observations
In trial 1, groups 1 and 2, the articulating sufaces of the
stifle were bluish to white, smooth and glistening (Fig 1 and 2).
Stifle cartilage changes were first detected in group III, dosed
at 3 times the proposed use level, in which 3 or 4 older puppies
developed lesions. The common lesions included surface
roughening, characterized by a dull, granular, grayish-yellow
appearance, and erosion, which was a deeper, ulcerative surface
defect. The distal patella, medial and lateral articular surfaces
of the tibia, and femoral condyles, were roughened and eroded.
A 3 X 4 mm bulla was found on the lateral trochlear ridge,
and another, 5 x 8 mm, was found on the lateral condyle of the
same femur. The vesicular lesions projected 1-2 mm above the
surrounding cartilage and were circular, unless located on the
trochlear ridges where they were elongated appearance. The
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larger vesicles or bullae were rarely intact, having been torn or
ruptured, producing large flaps of loose, smooth-surfaced, thin,
cartilage. The underlying eroded surface was roughened and
dull, with ragged edges, Subchondral bone was never exposed.
All 4 older pups, dosed at 5 times the proposed use level,
had stifle lesions. The least affected case developed a 4 x 5 mm
trochlear erosion and accompanying roughening of the tibial
articular surface. Of the remaining 3 cases, the patella of 1 had
a prolapsed, 6 x 6 mm "blister" and associated erosion of its
distal surface (Fig. 25). Erosions and cartilage tags were
present on the other patellar surfaces (Fig. 4 and 6).
The femoral trochlea had either 10 x 10 mm of surface
roughening, (Fig. 5 and 6), 8 x 12 mm focal erosion with
cartilagenous tags, (Fig. 3 and 4), or a 12 x 13 mm prolapsed
bulla (Fig. 24 and 25). In all cases, the lateral and medial
condyles developed roughened or eroded articular cartilage (Fig.
3, 5, and 24).
The younger puppies in trial 2 had stifle changes beginning
in group III, at 1.5 times the proposed use level, where 2 of 3
developed lesions. In both pups, the lateral tibiar surface was
roughened, and in addition, one had a 9 x 11 mm focal erosion
with cartilage detachment. The lateral condyle from the same
stifle developed a 6 x 9 mm erosion with cartilage tags.
At 2.5 times the proposed therapeutic dose, all 3 puppies
had stifle lesions. The medial condyles of each puppy developed
erosions, and the articular tibial surfaces, both medial and
40
lateral sides, were roughened and/or eroded.
Stifles examined from puppies treated at 3 times the proposed
usage level ranged from articulain one pup, two
intact vesicles were located in the intercondylar area. The same
femur had a trochlear ridge blister measuring 17 x 7 mm.
Another puppy had 3 vesicles, elliptically arranged, on its tibial
articular surface, an area not subject to direct appositional
forces
.
III. Microscopic Observation
Microscopically, the articulating cartilage of group I, in
both trials, had a smooth, undulating surface composed of the
flattened chondrocytes in zone 1, underwhich lay the randomly
oriented, well-dispersed chondrocyte population of zone 2,
followed by zone 3 chondrocyte columns and the calcified junction
found at zone 4 (Fig 7-9. 13, 19 and 33). The only interruption
in the normally smooth surface was due to the interwoven fibrous
attachment of ligaments or the synovial membrane (Fig 10-12).
Stifles which developed macroscopic lesions had
chondromalacia as a common microscopic lesion. Characterized by
loss of matrix stain uptake, resulting in a pale, often eosino-
philic appearance (Fig U and 15). Chondromalacic areas
generally had reduced numbers of chondrocytes, whith those
present often being hypertrophied or atrophied, with cytoplasmic
vacuolation.
The more advanced lesions with roughened and eroded
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surfaces developed cartilage fibrillation. Cartilage fibrillation
and chondromalacia were pronounced in the intermediate zone
(zone 2), (Fig 21-23), and also in foci of surface erosion (Fig
15-18, and 34).
Chondrocytes residing in areas of chondromalacia and
commonly encircling vesicles, formed clusters or "chondrones".
Chondromes were typically nests of 4 or more chondrocytes, with
their nuclei arranged in annular formation (Fig. 16). More
severe vesicular lesions, or cartilage tags, contained large,
mature chondrones, composed of up to 20 or more chondrocytes.
These clusters were the main cellular components wi cartilagenous
fronds, often containing multiple chondrones (Fig. 17 and 18).
The roughened articular surface of the tibia had characteristic
fissuring and fibrillation.
Cavitations of the intermediate zone developed most
frequently within the stifles of the higher dosage groups.
Chondrones, and disrupted, thickened, collagen fibers framed
these zone 2 cavities, under which often lay disorganized zone 3
chondrocyte columns (Fig. 20 and 26).
The macroscopic "blisters" corresponded to enlarged
cavitations, whose cartilagenous "roof projected above the
surface. The thin, protective, outer layer was pale staining, and
hypocellular, except for chondrocyte clusters, which were more
prominent along the sides and underlying borders (Fig. 32).
Several cavities contained small amounts of pale, eosinophilic
material. while other, larger vesicles, had some internal
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basophilic material, and cellular debris. Occasionally, once the
intervening thin, intact, articular surface had worn away, the
underlying cartilage was exposed, fibrillated and fissured, with
chondrones present along he lesion edge (Fig. 27).
Although, the Azure A stained slides did not contrast
strongly enough for good evaluation, the tissues stained by the
two Alcian Blue solutions vividly illustrated chondromalacia (Fig.
14 and 18). The proteoglycan-depleted matrix was pale, with
hypocellular foci, compared with a matrix normally deep blue in
color. Chondrones contrast with their background, as the
glycosaminoglycan-producing clusters stain blue, nestled in a
pale, wispy matrix.
Discussion
The development of articular changes was dose and age
dependent, although there were variations of lesion severity and
incidence among each group. Clinical observations did not
necessarily correspond with lesion severity. Examination of the
joints from those pups whose clinical signs of hindquarter
stiffness and weakness resolved, had marked gross and
microscopic lesions. One evident difference in results between the
2 trials was a total lack of patellar lesion development in trial
2, which was composed of younger puppies.
The grossly evident cartilage lesions had as their source a
common cascade of histological events. Chondromalacia, a key
^3
feature in pathogenesis, resulted from decreased proteoglycan
content, the ground substance for the cartilagenous matrix. The
softened cartilage is mechanically inadequate to support the
collagen framework, which becomes distorted, thickened, and
degenerated. In an emergency repair effort in the face of
increased destruction, 6 dusters of chondrocytes form to replenish
the matrix with chondroitin-4-sulfate. This is verified by their
deep blue appearance when stained with metachromatic Alcian
blue. The anticipated evaluation of the type and amount of
chondroitin sulfates present, based on subtle .5M and .9M Alcian
blue concentration differences, was not possible due to poor color
differentiation. However, over all proteoglycan depletion was
evident.
Normal articular hydrodynamics and resiliency are lost in
the collapsing, overly-hydrated matrix. 7 Unable to withstand
appositional pressures and shearing forces, the collagen
framework separates, resulting in internal cavitations. These may
evolve later into surface vesicles, and if ruptured, result in
marked focal cartilage effacement. Synovial fluid, with its
hyaluronidase component, gains wide access to the internal
cartilage, which enzymatically further degrades the matrix.
8
Results of research by Gough et al. on a similar
fluoroquinolone analogue study, were evaluated primarily by
vesicular and/or bullae formation within articular cartilage. 2
Modifications of this evaluation scheme were made to accommodate
the milder lesion of surface roughening, which was commonly
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observed in this study. Also, by separating the subtle
microscopic changes, the lesions' pathogenesis were more
thoroughly traced.
A theory derived from previous studies of fluoroquinolone-
mediated cartilage changes, suggested surface crystalline
formation. The crystals, when combined with appositional forces,
allegedly initiated articular cartilage destruction. In this study
lesions often developed within the metabolically active zone 2,
independent of surface influence (Fig. 20, 21, and 28).
Yet to be answered, is how the cascade of events is
initiated. Recent studies revealed two types of cartilage
degradation have been reported: (a) direct degradation by
enzymes, for instance, those released by synovial tissue; (b)
indirect degradation by factors, such as retinol and mononuclear
cell factor, which stimulate chondrocytes to produce matrix
degrading enzymes. 8-10 j^e results from these in vitro studies
mirror the cartilage changes produced from prolonged high levels
of fluoroquinolone. Mononuclear cell factor is believed to play a
major role in rheumatoid arthritisll,12 and osteo-arthritis.l3
These substances stimulate chondrocytes to release enzymes, which
focus their digestive abilities on the proteoglycan matrix set the
stage for further destruction.
Lesions produced in the present study were dosage
dependent, and their pattern and severity were reflective of the
dog's age. Why patellar lesions did not occur in younger
puppies but were consistently observed in slightly older pups, is
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unknown. Assuming the lesions are initiated by proteoglycan
loss, resulting in a weakened matrix, then lesion severity would
be influenced by increased physical activity and weight on the
the articular surfaces. Slightly older pups would be expected to
apply more stress through physical activity and increased body
mass, than smaller, less active, 3 month old pups.
Several studies reported that this antibiotic family did not
induced cartilage lesions in mature animals.2i3 Other research
comparing responses by young and old cartilage to various
substances tried to explain why differences occur. 14 Huber-
Bruning et al. conducted studies with retinol and mononuclear
cell factor on human cartilage in vitro from children (< 2-years-
old) and adults (> 40-years-old)
. They found proteoglycan
content shifts in both groups, though more severely in the young
than the old. Older cartilage tends to balance proteoglycan
release with greatly increased proteoglycan synthesis, so total
proteoglycan content remained unchanged. 16 Proteoglycan content
of young cartilage dropped due to enhanced release from
cartilage into the media, and suppression of proteoglycan
synthesis. Huber-Bruning concluded that naturally occurring
mononuclear cell factor can only exert a destructive effect on
cartilage that is actively synthesizing proteoglycan, a condition
met in older people with osteo-arthritis.l5 More studies are
required to explain some of these questions. The fluoroquinolone
antibiotic family offers great therapeutic promise, as well as
opportunities for future study.
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SUMMARY
Two groups of 15 puppies, each of different age ranges,
were histopathologically evaluated following various dosages of a
fluoroquinolone antibiotic. The stifle joints were examined for
macroscopic and microscopic articular cartilage changes. Grossly,
the lesions varied from surface roughening and erosion to vesicu-
lation and deep focal erosion and cartilage effacement. Micro-
scopic changes progressed from matrix depletion and cartilage
fibrillation to matrix fissuring, accented by chondrone formation,
zone 2 cavitations, surface vesiculation, and irregular foci of
cartilage fragmentation. The histological cascade which produced
the lesions began with destruction of the proteoglycan matrix.
Loss of matrix metachromasia when stained with Alcian blue,
demonstrated proteoglycan depletion. Cartilage changes were dose
and age dependent, though lesion severity and incidence varied
among groups. Notably, younger puppies did not develop patellar
lesions, as did older pups.
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Fig 1 - Normal articular surface of the distal femur and proximal
tibia.
Fig 2 - Normal femoral trochlea and patella.
Fig 3 - Roughened and eroded tibial articular surface. Erosion
and vesiculation of condylar and trochlear surfaces from
the stifle of a pup administered 5 times the therapeutic
dose.
Fig L, - The same stifle as in Fig 9. Deep focal trochlear erosion
with associated cartilagenous tag. Note focal patellar
erosion
.
Fig 5 - Stifle from a pup given 5 times the proposed usage level.
Roughened and eroded articular surface. Foci of deep
condylar erosion with a small vesicle noted on the
trochlear ridge.
Fig 6 - The same stifle pictured in Fig 11. Marked patellar
erosion with an associated cartilagenous tag. Deep,
circumscribed erosion of the proximal trochlear surface.
Small vesicle on lateral trochlear ridge.
50
J_ 8
_9 10
11 12
Fig 7 - Photomicrograph of normal cartilage of the femoral
condyle. H&E
A - Surface layer (zone 1)
B - Intermediate layer (zone 2)
C - Deep zone (zone 3)
D - Mineralization zone (zone U)
Fig 8 - Photomicrograph of normal articular cartilage from the
patella. Note well-defined zone 3 (C) chondrocyte
columns. H&E.
Fig 9 - Closer view of cartilage layers in Fig 1. Zone 1 (A)
contains small, flattened chondrocytes. Zone 2 (B)
chondrocytes are round and in various phases of
maturation. Zone 3 (C) has mature and hypertrophic
cells. Isogenous cell or cell nests are present. Zone 4
(D) represents the junction between the noncalcified and
calcified portions of cartilage. H&E
Fig 10 - Photomicrograph of normal interwoven attachment of the
fibrous synovial membrane and nonweight-bearing portion
of the articular surface. H&E
Fig 11 - Photomicrograph of normal blending of synovial membrane
with the nonweight-bearing articular cartilage surface of
the femoral head. The perichondral ring surrounds the
peripheral limits of the growth plate at the transition
point between articular cartilage and periosteum. H&E
Fig 12 - Photomicrograph of normal femoral head at the point of
round ligament attachment. H&F
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Fig 13 - Photomicrograph of normal articular cartilage. H&E
Fig U - Photomicrograph of Alcian blue stain demonstrating
moderate chondromalacia of the femoral condyle. Pitted,
roughened surface lacks a normal zone 1. Multiple]
active chondrones reside within zone 2. This area stained
darkly as compared to the rest of the pale matrix due to
proteoglycan production by the chondrones.
Fig 15 - Photomicrograph of marked chondromalacia of the femoral
condyle. Note pale, uneven, hypocellular zone 1 and
multiple, large chondrones reside within zone 2. H&E.
Fig 16 - Photomicrograph of large chondrones present in fibrillated
matrix from the tibial articular surface. H&E
Fig 17 - Photomicrograph of severe chondromalacia, fibrillation
and fissuring of the femoral condyle. Large chondrones
present in the projecting, pale, surface. H&E
Fig 18 - Photomicrograph of Alcian blue stain of the same tissue
in Fig 17. The territorial matrix, adjacent to
chondrocytes composing the chondrones, stained darkly
indicating presence of proteoglycans. The interterritorial
matrix is pale, indicating proteoglycan depletion and
chondromalacia
.
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Fig 19 - Photomicrograph of normal articular cartilage from the
femoral condyle. H&E
Fig 20 - Photomicrograph of zone 2 cavity in the femoral condyle.
Note multiple, large chondrones encircling the matrix
defect. The cartilage is hypocellular, fibrillated and
pale-staining along the cleft edges. H&E
Fig 21 - Photomicrograph of early cavity formation. The collagen
meshwork is distorted and the disrupted fibers have
separated. Medium-sized chondrones line the zone 2
defect. H&E
Fig 22 - Photomicrograph of Alcian blue stain of early cleft
formation within a femoral condyle. The darker areas
correspond to chondrone, or chondrocyte locations. the
pale area lacks metachromasia, indicating proteoglycan
depletion.
Fig 23 - Polarization of the same area in Fig 22. The mid-zonal,
light area, represents collagen fibers. Their wavy,
distorted, architecture highlights the defect. H&E
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Fig 24 - Stifle from a pup dosed at 5 times the proposed
therapeutic level. Note cartilage erosion of the tibial
surface. A prolapsed bulla is loosely attached to the
lateral trochlear ridge.
Fig 25 - Another view of loose, folded appearance to the smooth-
surfaced trochlear lesion. Bulla formation of the articular
patellar surface.
Fig 26 - Photomicrograph of a zone 2 cavity in the femoral
condyle in Fig 25. Note chondromalacia, fibrillation, and
chondrone formation associated with the cavity. H&E
Fig 27 - Photomicrograph the roughened tibial surface in Fig 24
and 25. Note cartilage tags, fissuring, and zone 2
cavitation. Chondrones in a pale-staining matrix
accentuated the cavity. H&E
Fig 28 - Photomicrograph of the femoral condyle had extensive
zone 2 clefting underlying the smooth articular surface
prior to the large, prolapsed bulla. H&E
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Fig 29 - Roughened and eroded tibial surface from a pup
administered 3 times the proposed therapeutic dose. A
small, intact bulla lies on the medial trochlear ridce(arrow). *
Fig 30 - Focal patella roughening and erosion. Intact bulla on
trochlear ridge (arrow).
Fig 31 - Higher magnification of the 3 x 4 bull in Fig 30.
Fig 32 - Photomicrograph of intact bulla. Two masses of cellular
debris are present inside the cavity. H&E.
Fig 33 - Photomicrograph of normal articular cartilage.
Fig 34 - Photomicrograph showing marked chondromalacia,
fibrillation, fissuring and chondrone formation of the
patellar surface. H&E
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APPENDIX A: Gross and Microscopic Lesions of Individual Pups,
Dog A . Group I Nontreated controls
TRIAL ONE
coxofe«orai stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(a) and cartilage effaceient
Microscopic
No significant aicroscopic lesion
Discrete areas of »atrix loss
Cartilage fibrillation
Chondrocyte clusters (cbondrones)
Fissuring of latrix
Interiediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross I
Large cavities in cartilage
Irregular fragaentation and loss of aatrix
acetabului
1 NVL
head
NVL
feiur
1 NVL
tibia
KVL
patella
NVL 1
1 1 1 1 i
1 1 1 1 1
1 1 1 i 1
1 1 1 , 1
X f X I X 1 X I X
Dog B. Group I Nontreated controls
coxofeioral
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(s) and cartilage efface»ent
Microscopic
No significant licroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Interaediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragmentation and loss of aatrix
stifle
acetabulum head feaur tibia patella
i NVL I NVL I NVL I KVL . KVL I
I I I
i I
62
Do9 C. Group I Nontreated controls
coxofeioral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(B) and cartilage effacesent
Microscopic
No significant licroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (cbondrones)
Fissuring of latrix
Interaediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragmentation and loss of latrix
acetabului
1 NVL
head
NVL
feaur
1 NVL
tibia
1 NVL
patella
NVL i
1 1 1 1 i 1
1 1 1 1 1 i
1 1 1 1 i 1
1 1 1 1 1 1
1 X X 1 X i X X 1
i 1 1 1 1 1
1 i 1 1 1 1
i 1 1 1 1 1
1 1 1 1 i f
1 1 1 1 i 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 i 1 1 i
Dog k. Group II: Proposed use level and 3 x duration of treatient
coxofeioral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
Kore than 2 vesicles and/or bulla
Deep erosion(8) and cartilage effaceient
Microscopic
No significant licroacopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Interaediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragientation and loss of latrix
acetabulua
I NVL i
head
NVL
feaur
NVL
tibia patella
I NVL ' NVL. ._^
X I X I X I X ! X
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Dog B. Group II: Proposed use level and 3 x duration of treatment
coxofeaoral stifle
Gross lesion
Surface rouaheninq
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep ero8ion(s) and cartilage effaceient
Nicroocopic
No significant licroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of satrix
Intenediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragientation and loss of latrix
Nicrocavitations not seen grossly
acetabulus head fenur tibia patella
1 NVL 1 NVL 1 NVL 1 NVL 1 NVL 1
1 1 1 i X 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
( X 1 X 1 X i > X 1
1 1 1 1 X i 1
1 1 1 1 X 1 1
1 1 1 1 1 i
1 1 1 1 1 1
i 1 1 1 i 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 X 1 1
1 1 1 i X i 1
Doq C. GrouD II: Pr<Aosed use level and 3 x duration of treatient
coxofeioral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(s) and cartilage effaceient
Kicroscopic
No significant licroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Intenediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross I,
Large cavities in cartilage
Irregular fragmentation and loss of latrix
acetabului
1 NVL
head
NVL
feiur
1 NVL
tibia
1 NVL
patella
NVL 1
1 1 1 1 X i i
1 1 1 i 1 1
1 1 1 1 ! 1
1 1 1 1 1 1
1 X X 1 X 1 X X 1
1 III
1 III
1 III
1 III
1 III
1 III
1 III
i III
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Do9 D. Group II: Proposed use level and 3 x duration of treataent
coxofeioral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosionCs) and cartilage effaceient
Microscopic
No significant licroscopic lesion
Discrete areas of tatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
loteraediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragientation and loss of latrix
Hicrocavitations not seen grossly
acetabului head feaur tibia patella
1 NVL i HVL i NVL 1 NVL 1 NVL 1
1 1 X 1 II 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 X 1 1 X 1 X 1 1
1 i X 1 II 1
1 1 X 1 1 1 X 1
1 1 X 1 1 i X i
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 X 1 II 1
1 1 X 1 1 1 X 1
Dog A. Group III: 3 x proposed use level and 3 x duration of treatn«it
coxofeaoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(s) and cartilage effaceaent
Microscopic
No significant aicroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Interaediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross i
Large cavities in cartilage
Irregular fragaentation and loss of aatrix
acetabulua head feaur tibia patella
l__ NVL I NVL I NVL I NVL i "xVL i
I X I I I
I I I I
I I I 1
I I I I
X I X I X I X i X
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Doa B . GrouD III: 3 x oroDosed use level and 3 x duration of treatient
eoxofetoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deeo erosion(6) and cartilaqe effaceient
acetabulua
i NVL
head
NVL
feiur
1 NVL
tibia
1 NVL
patella
NVL 1
1 X X 1 X 1 X X 1
1 1 1 1 1 1
1 1 1 X 1 1 1
X 1 X 1 X 1
Microscopic
No significant licroscopic lesion
Discrete areas of *atrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Interiediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross j
Large cavities in cartilage
Irregular fragmentation and loss of aatrix
I I I I X
X I X I X i X i
I X I X I X I
I X I X I I
I X I X I X I
I X I i i
i X I I X I
I X I I I
I X I X I X i
Dog C. Group III: 3 x proposed use level and 3 x duration of treatient
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion (s> and cartilage effaceient
coxofeKiral
head
NVL
stifle
acetabului
1 NVL
feiur
1 NVL
tibia
1 NVL 1
patella
NVL i
1 x X 1 1 X 1 X 1
1 1 1 1 1 1
1 1 1 1 i 1
1 X 1 i X 1 X 1
Microscopic
Ho significant licroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
_
Interiediate (zone 2) cavitations |_
Elevation of cartilage surface correlating with gross \_
Large cavities in cartilage ]_
Irregular fragmentation and loss of latrix ]_
I
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Dog D. Group III: 3 x proposed use level and 3 x duration of treatient
coxofe«oral stifle
Gross lesion
Surface rouqheninq
1 or 2 vesicles and/or bulla
Hore than 2 vesicles and/or bulla
Deep ero8ion(s) and cartilaqe effaceaent
Bicroscopic
No significant aicroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Interiediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragaentation and loss of aatrix
acetabului
1 NVL
head
NVL
feaur
1 NVL
tibia
1 NVL
oatella
'nvl 1
1 X X 1 X 1 xl X (
1 1 1 1 i 1
1 1 1 1 1 1
1 X X 1 X 1 X X i
1 III i
1 X X 1 X i X X i
1 X 1 X i X X
1 X I X i i
1 X 1 X i X t
1 X 1 X 1 X !
1 X 1 X i i
1 III i
1 X 1 X 1
Doq A. GrouD IV: 5 x orooosed use level and 3 x duration of treataent
coxofeaoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
Kore than 2 vesicles and/or bulla
Deep erosion (s) and cartilage effaceaent
Microscopic
No significant aicroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Interaediate (zone 2> cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragaentation and loss of aatrix
acetabulua head feaur tibia patella
I HVL I NVL I NVL I NVL i NVL I
I X I X I X I x
I I I I
I I I I
I X I X I i
X t I I I X
I X I X ! X '
I X i X I X I
I X I I i
I X i X i X i
I X I X I X I
I X I X I X i
I I I i
i X i X I X i
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Doq B. GrouD IV: 5 x orooosed use level and 3 x duration of treatnent
coxoie«orai stifle
acetaouxui
I KVL
head
KVLGross lesion
Surface rouqheninq
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(s) and cartilaqe effaceient
Microscopic
No significant aicroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Intenediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross |
Large cavities in cartilage
Irregular fragaentation and loss of iiatrix
Doq C. GrouD IV: 5 X orooosed use level and 3 x duration of treatment
feaur tibia patella
I SVL I m. i SVL i
x I x I X I X I X
I I I I
I I X i I
I X I X I X f X
X I X i X I X I X
X I X I X I X i X
X I X I X I X i X
I X I X I X i X
X I X t X I X
I 1 i
X I X I X ' X
coxofeaoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bulla
Deep erosion(6) and cartilage effaceient
Microscopic
No significant licroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Interaediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross [
Large cavities in cartilage
Irregular fragaentation and loss of aatrix
acetabulua head feaur tibia patella
i NVL i KVL I NVL I NVL I KVL i
X I X I X ! X ' X
I i I !
I I I I
I X I X I I X
X I
\
t I
I X I X i X I X
I X I X I X i X
I X I X I X I X
I X I X I X I X
I X I X I X i X
I X I X I X ' X
I
!
I i
I X I X i X i X
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Doq D. Group IV: 5 x proposed use level and 3 x duration of treataent
coxofeaoral stifle
Gross lesion
Surface rouahenina
1 or 2 vesicles aod/or bulla
More than 2 vesicles and/or bulla
Deep erosion(a) and cartilage effaceient
Microscopic
No significant aicroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Interiediate (zone 2) cavitations
Elevation of cartilage surface correlating with gross
Large cavities in cartilage
Irregular fragaentation and loss of aatrix
acetabulua
1 NVL
head
NVL
feaur
1 NVL
tibia
1 NVL
patella
'nvl 1
1 X X 1 X 1 X X 1
1 III 1
1 III 1
1 1 X 1 X X 1
1 X X 1
1 i X 1 X X 1
1 1 X 1 X X i
1 1 X 1 X X 1
1 1 X 1 X X )
1 1 X ( X X 1
1 1 X 1 X X 1
1 1 1 1 1 1
1 1 X 1 X X 1
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Iw A. Group I Nontreated Controls
TRIAL TWO
coxoie«orai StlllS
Gross lesion
Surface rouqhenina
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep ero8ion(s) and cartilage effaceient |
Sicroscopic
No significant icroacopic lesion
Discrete areas of «atrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Microcavitations
Interiediate (zone 2) cavitations
Elevation oi surface = gross
Large cavities in cartilage
Irregular fragmentation & loss of latrix
acetabulu» head fenur tibia catelia
i NVL > NVL .WL ' XVI i KVL
t 1 , 1
i
:
1 1 i I i i
1 i 1 i 1 1
1 i
i i
! X i X X X i X i
i 1 1 1 1
( i 1 i 1
1 1 1 1 !
1 i 1 1 1
i i i 1 1
i 1 1 1 1
1 1 1 1 ;
! 1 1 ;
I 1 1 1
Dog B. Group I Nontreated Controls
^jrosfi lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(8) and cartilage effaceient
Microscopic
No significant iicroscopic lesion
Discrete areas of «atrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of «atrix
Microcavitations
Interiediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragientation & loss of natrix
coxofeioral stifle
acetabului head fe»ur tibia oatella
i NVL 1 NVL 1 NVL 1 NVL 1 NVL
1 i 1 1 i 1
1 1 1 1 1 1
) 1 1 j 1 i
1 1 i ; i ,
1 X i X 1 X X i X
1
! i ! i ;
'
1 i i i
1 1 1 i 1 i
i i 1 1 j 1
i
1 i 1 1 1
i
i 1 i i 1
* 1 1 1 i i
i ill)
! i ( 1 i
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Ew C. Group I Nontreated Controls
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(s) and cartilage effaceient
Microscopic
No significant licroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of »atrix
Sicrocavitations
Inter»ediate (zone 2) cavitations
Elevation oi surface = gross
Large cavities in cartilage
Irregular fragientation & loss of latrix
coxofe»oral
acetabulu* head fe«ur
stifle
MVL i m. \ WL
tibia
i XVL
patella
i NVL
I
X I
i
Dog A. Group II 0.5 x proposed use level for 30 consecutive days
coxofe«oral stifle
Gross lesion
Surface roughening i
1 or 2 vesicles and/or bulla i
More than 2 vesicles and/or bullae i
Deep erosion(s) and cartilage efface«ent I
Microscopic
No significant licroscopic lesion i
Discrete areas of latrix loss i
Cartilage fibrillation
i
Chondrocyte clusters (chondrones) i
Fissuring of «atrix J
Microcavitations
i
Intermediate (zone 2) cavitations 7
Elevation of surface = gross i
Large cavities in cartilage i_
Irregular fragientation & loss of «atrix i
acetabului head fe«ur tibia patella
I WL I KVL I tiVL I .Wl I NVL
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Dog B. Group II 0.5 x proposed use level for 30 consecutive davs
stiflecoxofeioral
acetabului head fe»ur tibia patella
uross lesion (_
Surface roughening i
1 or 2 vesicles and/or bulla i_
Kore than 2 vesicles and/or bullae j_
Deep erosion(8) and cartilage effaceient j_
NVL
Microscopic
No significant iicroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
rissuring of iiatrix
Kicrocavitations
Interiediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragientation & loss of «atrix
XVL I .VVL I XVL
I I
SVL
X I XI X I X I X
Dog C. Group II 0.5 x proposed use level for 30 consecutive days
coxofeaoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(s) and cartilage efface«ent
Microscopic
So significant «icroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
rissuring of «atrix
Microcavitations
Interiediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragmentation & loss of natrix
acetabulum head fe«ur
NVL XVL > KVL
tibia patella
XVL
i
X I X I X I X I x
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Ooq A. Grouo III i.5 X proposed use level for 30 consecutive days
coxofeioral stifle
Gross lesion
i
Surface roughening |i_
1 or 2 vesicles and/or bulla ]_
More than 2 vesicles and/or bullae |_
Deep ero8ion(s) and cartilage effaceient i_
acetabului head fe«ur tibia patella
Microscopic
No significant licroscopic lesion i^
Discrete areas of »atrix loss
J_
Cartilage fibrillation i_
Chondrocyte clusters (chondrones) I
Fissuring of «atrix i
Hicrocavitations i
Interiediate (zone 2) cavitations i_
Elevation of surface = gross
J_
Large cavities in cartilage ]_
Irregular frag»entation & loss of latrix l_
NVL I KVL I yes yes
I X
WL
Dog B. Group III 1.5 x proposed use level for 30 consecutive days
coxofe«oral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(8; and cartilage effaceient
Microscopic
No significant licroscopic lesion
Discrete areas of «atrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Microcavitations
Interiediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragientation & loss of latrix I
acetabului head feiur tibia oatella
1 NVL i NVL i NVL 1 NVL • NVL i
i 1 i 1 j 1
1 1 1 1 1 i
< 1 1 1 j 1
1 1 i 1 < !
IX i 1 i i x •
• 1 X 1 X 1 X 1 1
1 1 X 1 1 X (
i f 1 1 1 i
i 1 1 1 1 ,
• 1 1 1 1 1
1 I 1 1 1 (
i 1 1 1 1 j
< 1 1 1 i 1
1 II!,
i
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Dog C. Group III 1.5 x proposed use level for 30 consecutive days
coxofeBoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(s) and cartilage effaceaent
Microscopic
No significant licroscopic lesion
Discrete areas of «atrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Nicrocavitations
Intenediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragmentation & loss of latrix
acetabulut head fepur tibia oatelia
1 NVL 1 NVL i NVL 1 ves i NVL '
1 II 1 X i 1
1 III! I
1 i 1 1 1 i
1 1 1 1 1 1
1 X 1 X i X 1 X 1 X 1
i 1 1 1 1 1
1 1 1 1 1 i
1 1 1 1 J 1
1 1 1 1 1 1
1 1 1 1 1 i
1 1 1 1 1 1
1 till 1
1 1 1 1 1
1 1 1 1 1 1
Dog A. Group IV 2.5 x proposed use level for 30 consecutive days
coxofenoral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(8) and cartilage effacetent
flicroscopic
No significant licroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Nicrocavitations
Intenediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragtentation & loss of aatrix
acetabului head feiur tibia oatelia
1 NVL 1 NVL 1 ves 1 yes i NVL i
1 1 1 X 1 X 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 X 1 X 1 1
1 X 1 X 1 1 1 X i
1 1 1 X 1 X 1 1
1 II 1 X 1 i
1 II 1 X 1 1
1 II 1 X 1 1
1 II 1 X 1 1
1 1 1 1 1 1
1 II 1 X 1 1
1 1 1 1 1 1
1 1 1 1 1 1
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Dog B. Group IV 2.5 x proposed use level for 30 consecutive days
coxofenoral stifle
acetabului head fe«ur tibia patella
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(s) and cartilage effaceaent
Microscopic
No significant licroscopic lesion
Discrete areas of »atrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Hicrocavitations
Interiediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragaentation & loss of Matrix
1 NVL 1 yes 1 yes I yes 1 KVL 1
1 1 X 1 X 1 X 1 1
1 1 1 1 1 1
1 1 1 1 i 1
1 1 1 X 1 X 1 1
IX i 1 1 1 X 1
1 1 X i X ( X 1 1
1 1 X 1 X 1 X i 1
1 1 X 1 X 1 X i i
1 / X 1 X 1 1 1
1 1 X 1 X 1 X 1 i
1 1 X 1 X 1 X i 1
1 1 X 1 X 1 X i i
1 1 1 X 1 1 1
1 1 X 1 X i X i 1
Dog C. Group IV 2.5 x proposed use level for 30 consecutive days
coxofeaoral stifle
acetabului head feiur tibia patella
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(s) and cartilage effaceient
Microscopic
No significant licroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of aatrix
Hicrocavitations
Interaediate (zone 2) cavitations
Elevation of surface - gross
Large cavities in cartilage
Irregular fragaentation & loss of aatrix
1 NVL 1 yes i yes i yes 1 SVL i
1 1 X i X 1 X i i
1 1 1 1 1 i
1 1 X 1 X 1 X 1 1
1 1 1 i 1 i
1 II 1 1 X 1
1 X 1 X 1 X 1 X 1 (
1 1 X 1 X 1 X 1 !
1 X 1 X 1
1 X 1 X 1
1 X 1 X 1
1 X i X 1
1 X 1 X 1
1 1 1 X 1 1 .1
1 1 1 X 1 X 1 1
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Dog A. Group V 3 x proposed use level for 15 consecutive days
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
Hore than 2 vesicles and/or bullae
Deep ero8ion(s) and cartilage effaceient
Microscopic
No significant licroscopic lesion
Discrete areas of latrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of latrix
Microcavitations
Intenediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragientation & loss of aatrix
coxofeioral stifle
acetabului head feiur tibia oatella
1 NVL 1 MVL 1 yes 1 yes 1 NVL 1
1 1 1 X 1 X 1 1
i 1 1 1 1 1
1 1 1 1 1 1
1 1 1 X 1 X 1 1
1 X II 1 1 X 1
1 1 X 1 X 1 X 1 1
1 1 X 1 X 1 X 1 1
1 1 1 X 1 X 1 1
1 1 1 X 1 X 1 1
1 1 1 X 1 X 1 1
1 1 1 X i X 1 1
1 1 1 X 1 X 1 1
1 1 1 1 1 1
1 1 1 X 1 X 1 1
Dog B. Group V 3 x proposed use level for 15 consecutive days
coxofenoral stifle
I
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
_
Bore than 2 vesicles and/or bullae ]_
Deep erosion(s) and cartilage effaceient \_
acetabului head fe»ur tibia patella
I NVL I yes I yea I yes I NVL I
I
I X I
I X I I I
I
I
Microscopic
No significant licroacopic lesion
J_
Discrete areas of latrix loss ]_
Cartilage fibrillation j_
Chondrocyte clusters (chondrones) \_
Fissuring of latrix \_
Microcavitations
]_
Intenediate (zone 2) cavitations ]_
Elevation of surface = gross {_
Large cavities in cartilage ]_
Irregular fragientation & loss of latrix i
I X I
I X I
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Do9 C. Group V 3 x proposed use level for 15 consecutive days
coxofe»oral stifle
Gross lesion
Surface roughening
1 or 2 vesicles and/or bulla
More than 2 vesicles and/or bullae
Deep erosion(s) and cartilage effacetent
Microscopic
No significant licroscopic lesion
Discrete areas of aatrix loss
Cartilage fibrillation
Chondrocyte clusters (chondrones)
Fissuring of *atrix
Hicrocavitations
Internediate (zone 2) cavitations
Elevation of surface = gross
Large cavities in cartilage
Irregular fragmentation & loss of *atrix
acetabului head feiur tibia oatella
1 NVL 1 MVL 1 yes 1 ves 1 NVL 1
1 1 1 X 1 X 1 1
1 II 1 X 1 1
1 II 1 X 1 1
1 X 1 X 1 X 1 1 X 1
I II 1 X 1 1
1 II 1 X 1 1
1 II 1 X 1 1
1 II 1 X 1 1
1 II 1 X 1 1
1 II 1 X 1 1
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APPENDIX B: Continuing in vitro Research on Fluoroquinolone-
raediated Articular Changes
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INTRODUCTION
In vitro degradation of cartilage has been induced by
retinol and mononuclear cell factor. 1,2, 3 Cartilagenous changes
occur through stimulated degradative activities of chondrocyte-
produced enzymes. Indirect degradation demonstrated by these
experiments paralleled closely the described articular cartilage
lesion pathogenesis from prolonged high level fluoroquinolone
antibiotic administration in immature dogs. Based upon this
similarity, in vitro studies using living and dead cartilage
explants, was performed to see if degradative changes, produced
indirectly, would occur in cartilage removed from all pressure
and weight-bearing demands.
MATERIALS AND METHODS
Tissues:
Normal articular cartilage was obtained aseptically from the
distal femurs of a 11 kg, 4 1/2-months-old, Chow cross pup.
Tissue Culture:
Slices of sterile articular cartilage, varying in size from 5-8
mm by 2-4 mm, and of full cartilage thickness, (range 2-3 mm)
were placed individually, and at random, in a multiwell tissue
culture plate (6-well, 35 x U mm. Falcon 3046: Becton Dickenson
Labware, Oxnard, CA). There were 5 test groups, with two pieces
80
of cartilage per group. The pieces were placed in media with a
pure fluoroquinolone antibiotic.
Group Fluoroquinolone Concentrations
C Control
A
.5 proposed usage level
B 1.5 X proposed usage level
D 2.5 X proposed usage level
DD Killed cartilage, bathed in
2.5 X proposed usage level
The basic culture media consisted of: 100 ml Dulbecco's modified
Eagle's medium (DMEM), 10 ml inactivated fetal calf serum, 12
mg/100 ml ascorbic acid, 1 ml .5g/100 ml gentamycin, .25 ml
fungizone. The antibiotic calculations were based on a 10 kg dog
having 7.1 water and 4 ml media/well. The two dead cartilage
explants were thrice frozen and thawed in liquid nitrogen.
The tissue plates were placed in a moist chamber, gassed
with a mixture of 20% 0^, 75% N2, and 5% CO2. and incubated at
35 C. Media and antibiotic solutions were changed twice, at
every fourth day. On the eighth day of culture, the cartilage
pieces were prepared for transmission electron microscopy and
routine histology. The media which had bathed the explants and
been drawn off twice, was frozen for future proteoglycan content
analysis.
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RESULTS
Tissue examination under light microscopy using H&E stain:
Group Matrix Chondrocytes Clefting
C Strong, sharp
eosinophilic.
Even cellular
tribution
&
dis-
Round & darkly
nucleated
None
A Pale, pink &
hypocellular
zone 2. Few
empty lacunae
Cytoplasmic vac-
uolization. Some
stained eosinophilic
Present
B* Pale, pink & Zones 1 & 2 have Present
hypocellular. pyknotic, dark nuclei
Some empty lucunae & cytoplasmic vacuolization
Pale, pink &
hypocellular.
Empty lacunae
Eosinophilic with small Present
pyknotic nuclei, or
eosinophilic nuclei
DD Eosinophilic, well- Shrunken, pyknotic
defined empty chondrocytes
lucunae
Present
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*One sample became contaminated by fungal growth.
In groups A, B and D, diagonal to horizontal clefting was
associated wit a pale-staining, hypocellular matrix, composed of
prominent collagen fibers and eosinophilic chondrocytes, often
containing dark, pyknotic nuclei. Ocassionally, a pale,
basophilic, acellular substance lined some clefts.
Preliminary examinations by electron microscopy indicated
chondrocytes in groups A, B, and D, had undergone marked
cytoplasmic vacuolization. The extent of the changes appeared to
be dose related, with group A chondrocytes less affected than
those in group D. Further results are pending.
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Fig 1 - Photomicrograph of chondrocyte from the control cartilage
explant x 5,000.
Fig 2 - Higher magnification photomicrograph of the cytoplasmic
organelles in Fig 1. Note well-defined mitochondria,
lysosomes and Golgi apparatus x 20,000.
Fig 3 - Photomicrograph of a chondrocyte bathed in media con-
taining
.5 times proposed usage level of fluoroquinolone.
Note vesiculated cytoplasm x 15,000.
Fig 4 - Photomicrograph of a chondrocyte exposed to 1.5 times
proposed usage level of fluoroquinolone. Note "softened"
outline and vesiculated cytoplasm containing electron-
dense, amorphous material x 20,000.
Fig 5 - Photomicrograph of a chondrocyte bathed in media with
2.5 times proposed usage level. Membrane outlines are
indistinct and multifocal to coalescing electron-dense
amorphous material fills the vesiculated cytoplasm x
5,000.
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Fig 6 - Photomicrograph of a chondrocyte exposed to 2.5 times
proposed Huoroquinolone usage level. Note the vesiculated
cytoplasm x 5,000.
Fig 7 - Photomicrograph at higher magnification of the
chondrocyte in Fig 6. Small cytoplasmic vesicles are
present adjacent to larger, vacuolated areas. The
mitochondria and other organelle membranes are distinct
X 10,000.
Fig 8 - Photomicrograph of a chondrocyte bathed in media with
2.5 times proposed fluoroquinolone usage level. Note
poorly defined organelle membranes and cytoplasmic
vacuoles containing amorphous, electron-dense material x
7,000.
Fig 9 - Photomicrograph of a killed chondrocyte, which had been
exposed to fluoroquinolone at 2.5 times proposed usage
level. A homogenously electron-dense nucleus resides in a
lytic, ill-defined, mottle cytoplasm x 15,000.
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The promising broad-spectrum antibiotics comprising the
fluorquinolone family, mediate changes in cartilage in the major
joints of juvenile dogs. The dose and age-dependent degradative
process initiates proteoglycan loss from the cartilage matrix. The
collagen/proteoglycan framework weakens, loses resiliency, and
becomes susceptible to damage by normal, weight-bearing
pressures.
Two groups/of 15 dogs each, were histopathologically
evaluated following 30-day pharmaceutical trials. In group 1,
5-7-months-old pups were orally treated either at the proposed
usage level, or 3 or 5 times that dosage, for a period amounting
to 3 times the proposed treatment duration. In the second group,
3-A-months-old puppies received daily oral doses .5, 1.5, 2.5, or
3 times the proposed usage level, for 30 days, or 3 times the
proposed treatment duration.
Grossly, typical coxofermoral and stifle lesions found
in groups 1 and 2 pups, which received the high dosages,
included roughening, "blistering", or deep erosion of the
articular joint surface. The vesicular lesions were characterized
by a smooth, thin, cartilagenous surface, which had frequently
torn to, reveal focal cartilage effacement. Accompanying
microscopic changes were typified by proteoglycan loss, best
illustrated by Alcian blue staining, progressing to collagen
fibrillation, chondrocyte clusters, clefts within zone 2, and
vesicular formation. Notably, group 1 puppies developed
ulcerative lesions of the patella, which were not observed in the
younger, group 2 pups.
This study illustrated progression of the articular cartilage
lesions but not the mechanism initiating the degeneration.
?L.-Aa
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*One sample became contaminated by fungal growth.
In groups A, B and D, diagonal to horizontal clefting was
associated wit a pale-staining, hypocellular matrix, composed of
prominent collagen fibers and eosinophilic chondrocytes, often
containing dark, pyknotic nuclei. Ocassionally, a pale,
basophilic, acellular substance lined some clefts.
Preliminary examinations by electron microscopy indicated
chondrocytes in groups A, B, and D, had undergone marked
cytoplasmic vacuolization. The extent of the changes appeared to
be dose related, with group A chondrocytes less affected than
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Fig 1 - Photomicrograph of chondrocyte from the control cartilage
explant x 5,000.
Fig 2 - Higher magnification photomicrograph of the cytoplasmic
organelles in Fig 1. Note well-defined mitochondria,
lysosomes and Golgi apparatus x 20,000.
Fig 3 - Photomicrograph of a chondrocyte bathed in media con-
taining
.5 times proposed usage level of fluoroquinolone.
Note vesiculated cytoplasm x 15,000.
Fig 4 - Photomicrograph of a chondrocyte exposed to 1.5 times
proposed usage level of fluoroquinolone. Note "softened"
outline and vesiculated cytoplasm containing electron-
dense, amorphous material x 20,000.
Fig 5 - Photomicrograph of a chondrocyte bathed in media with
2.5 times proposed usage level. Membrane outlines are
indistinct and multifocal to coalescing electron-dense
amorphous material fills the vesiculated cytoplasm x
5,000.
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Fig 6 - Photomicrograph of a chondrocyte exposed to 2.5 times
proposed Huoroquinolone usage level. Note the vesiculated
cytoplasm x 5,000.
Fig 7 - Photomicrograph at higher magnification of the
chondrocyte in Fig 6. Small cytoplasmic vesicles are
present adjacent to larger, vacuolated areas. The
mitochondria and other organelle membranes are distinct
X 10,000.
Fig 8 - Photomicrograph of a chondrocyte bathed in media with
2.5 times proposed fluoroquinolone usage level. Note
poorly defined organelle membranes and cytoplasmic
vacuoles containing amorphous, electron-dense material x
7,000.
Fig 9 - Photomicrograph of a killed chondrocyte, which had been
exposed to fluoroquinolone at 2.5 times proposed usage
level. A homogenously electron-dense nucleus resides in a
lytic, ill-defined, mottle cytoplasm x 15,000.
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